| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
63,781 |
60,919 |
$15.03M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
56,467 |
54,531 |
$8.35M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
21,691 |
20,508 |
$7.23M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
32,811 |
31,284 |
$4.25M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
18,485 |
14,735 |
$1.34M |
| 71046 |
Radiologic examination, chest; 2 views |
17,516 |
16,662 |
$900K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
15,592 |
14,109 |
$804K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
18,635 |
17,304 |
$681K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
15,571 |
3,845 |
$617K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
15,129 |
4,320 |
$611K |
| 71045 |
Radiologic examination, chest; single view |
7,215 |
6,762 |
$385K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
52,735 |
44,804 |
$383K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,837 |
8,454 |
$369K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,373 |
1,324 |
$355K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
10,797 |
3,390 |
$340K |
| 97597 |
|
7,229 |
2,414 |
$339K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,671 |
3,584 |
$304K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,500 |
3,448 |
$303K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
551 |
380 |
$284K |
| 59025 |
Fetal non-stress test |
1,976 |
1,598 |
$267K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,883 |
2,735 |
$264K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,487 |
3,436 |
$134K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
717 |
353 |
$126K |
| 64615 |
|
459 |
416 |
$78K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,605 |
1,387 |
$54K |
| 62323 |
|
103 |
99 |
$40K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
99 |
93 |
$39K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
84 |
83 |
$35K |
| 95912 |
|
118 |
105 |
$34K |
| 96367 |
|
258 |
116 |
$32K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
223 |
205 |
$28K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
183 |
172 |
$26K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,074 |
338 |
$23K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
28,884 |
26,548 |
$18K |
| 80053 |
Comprehensive metabolic panel |
66,326 |
62,395 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
11,389 |
9,462 |
$17K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
543 |
524 |
$17K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
41 |
40 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
70,034 |
65,455 |
$14K |
| 20611 |
|
61 |
52 |
$12K |
| 87536 |
|
182 |
162 |
$10K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
773 |
605 |
$10K |
| G0379 |
Direct admission of patient for hospital observation care |
462 |
366 |
$10K |
| 64493 |
|
16 |
15 |
$10K |
| 97803 |
|
512 |
493 |
$9K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
818 |
191 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,662 |
2,529 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
277 |
266 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
277 |
266 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
16,001 |
15,314 |
$5K |
| 83605 |
|
21,600 |
19,338 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,671 |
8,245 |
$4K |
| 86360 |
|
119 |
106 |
$4K |
| 83690 |
|
24,649 |
23,559 |
$3K |
| 87400 |
|
12,571 |
6,028 |
$3K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
13 |
12 |
$3K |
| G0378 |
Hospital observation service, per hour |
833 |
563 |
$3K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
25 |
24 |
$3K |
| 81003 |
|
12,890 |
12,372 |
$2K |
| 86738 |
|
2,150 |
2,016 |
$2K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
20 |
12 |
$2K |
| 97161 |
|
32 |
32 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
41 |
40 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,327 |
11,526 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,888 |
7,179 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
56 |
24 |
$2K |
| 97802 |
|
137 |
128 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,824 |
2,299 |
$2K |
| 97162 |
|
23 |
23 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,507 |
4,649 |
$1K |
| 83735 |
|
19,981 |
18,888 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
18 |
16 |
$1K |
| 83655 |
|
96 |
83 |
$1K |
| 87522 |
Neg quan hep c or qual rna |
25 |
25 |
$1K |
| 81025 |
|
10,864 |
10,528 |
$999.82 |
| 80061 |
Lipid panel |
104 |
96 |
$934.99 |
| 76642 |
|
12 |
12 |
$890.78 |
| 97165 |
|
14 |
13 |
$802.77 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,643 |
5,403 |
$671.30 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$670.53 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
276 |
270 |
$669.06 |
| 95886 |
|
995 |
850 |
$618.16 |
| 81001 |
|
25,572 |
24,478 |
$571.70 |
| 84484 |
|
18,614 |
14,604 |
$505.59 |
| 86592 |
|
161 |
146 |
$482.17 |
| 97598 |
|
46 |
25 |
$480.54 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
280 |
267 |
$447.30 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
447 |
422 |
$416.33 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
9,105 |
8,675 |
$374.12 |
| 87081 |
|
4,300 |
4,175 |
$307.97 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
26 |
12 |
$291.14 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,666 |
3,493 |
$236.41 |
| 86361 |
|
13 |
12 |
$221.85 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
505 |
464 |
$217.08 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,843 |
1,700 |
$214.46 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
136 |
126 |
$213.59 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
14 |
12 |
$208.02 |
| 72100 |
|
16 |
13 |
$199.24 |
| 84443 |
Thyroid stimulating hormone (TSH) |
136 |
124 |
$176.81 |
| 85610 |
|
2,423 |
2,283 |
$172.91 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
42 |
36 |
$170.69 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
45 |
43 |
$161.08 |
| 87420 |
|
871 |
852 |
$159.23 |
| 86803 |
|
15 |
13 |
$156.96 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
262 |
233 |
$152.09 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
438 |
421 |
$137.13 |
| 85018 |
|
59 |
51 |
$133.68 |
| 82803 |
|
2,077 |
1,909 |
$112.80 |
| 86900 |
|
51 |
49 |
$108.23 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
14 |
14 |
$99.62 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
301 |
286 |
$92.17 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17 |
17 |
$78.84 |
| J1790 |
Injection, droperidol, up to 5 mg |
79 |
76 |
$77.42 |
| 83880 |
|
418 |
394 |
$74.88 |
| 82550 |
|
882 |
819 |
$66.87 |
| 84100 |
|
257 |
203 |
$50.91 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
632 |
595 |
$50.20 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
162 |
147 |
$44.44 |
| 85379 |
|
627 |
597 |
$40.06 |
| 83615 |
|
73 |
66 |
$37.58 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
285 |
261 |
$28.47 |
| 86141 |
|
327 |
317 |
$25.34 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
42 |
36 |
$24.76 |
| 85027 |
|
282 |
261 |
$24.17 |
| 85730 |
|
489 |
466 |
$23.52 |
| 82009 |
|
846 |
803 |
$21.89 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
29 |
27 |
$16.76 |
| 84702 |
|
121 |
111 |
$14.73 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
45 |
38 |
$11.71 |
| 82948 |
|
206 |
100 |
$10.95 |
| 87186 |
|
56 |
55 |
$8.47 |
| 87077 |
|
13 |
13 |
$7.91 |
| 84703 |
|
297 |
293 |
$7.35 |
| 87040 |
|
994 |
549 |
$6.64 |
| A9270 |
Non-covered item or service |
1,421 |
1,248 |
$0.24 |
| 64494 |
|
15 |
14 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
18 |
18 |
$0.00 |
| 87070 |
|
45 |
37 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13 |
12 |
$0.00 |
| 74022 |
|
36 |
36 |
$0.00 |
| 86901 |
|
55 |
52 |
$0.00 |
| 86850 |
|
28 |
28 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
13 |
12 |
$0.00 |
| 87581 |
|
14 |
14 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
13 |
12 |
$0.00 |
| 85651 |
|
15 |
15 |
$0.00 |
| 88304 |
|
12 |
12 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
14 |
13 |
$0.00 |
| 96376 |
|
23 |
22 |
$0.00 |
| 87210 |
|
115 |
113 |
$0.00 |
| 80076 |
|
140 |
137 |
$0.00 |
| 73630 |
|
15 |
14 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
58 |
53 |
$0.00 |
| 73130 |
|
16 |
15 |
$0.00 |
| 73610 |
|
14 |
14 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
13 |
12 |
$0.00 |